madamswer
But you're always expressing a "reluctance to buy shares in the company because of [let's call them X] very factor."
Just throw in random risks, real and imaginary, and stir vigorously. Then repeat. Yes, you gave a supposed deadline and there was nothing, zero, niet about context or other upside. You want total certainty? Nobody credible can discuss stocks like that. It generates fear. There will always be some uncertainty and risk, it's a question of degree, and in assessing that, you need context.
You can't say there is zero upside. That's absurd. You can't say there is no chance any deal with come, that's also absurd.
There are so many of supposed X factors regarding risk and hardly any [lets call them] Y factors regarding reward in your assessments let alone a measured ability to weigh them.....
It's always, this isn't certain, that isn't certain, we haven't got certain revenue here or there.
There is never a comprehensive analysis based on the strategic advantages that the company has, the advanced state of the technology looking at the matter in entireity....and comparing them as Y to your so called risk X.
No wonder antibody is saying you don't know how to assess risk, and give it appropriate rating relative to reward, and I agree with him totally.
You can't exaggerate the element of risk and have no context for your claims. It's not a genuine assessment.
Risk v Reward.
There's colossal reward in there with MSB IMO, and very reduced risk, but it takes a long time to explain it and have to reexplain it each time a lazy poster raises some point in isolation.
This is why antibody and some other very well informed posters make reference to the upside, or reference to risk in a wider context. It's the context that any reasonable analyst would understand.
LT holders have grasped this long ago and most don't respond to the near daily barrage in here.
They understand what they've got.
DYOR people.
Ask yourself if the top 200 are selling? Or is it just retail investors getting churned by the big boys.
- Forums
- ASX - By Stock
- MSB
- Trading high volume
MSB
mesoblast limited
Add to My Watchlist
1.47%
!
$1.73

Trading high volume, page-107
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.73 |
Change
0.025(1.47%) |
Mkt cap ! $2.207B |
Open | High | Low | Value | Volume |
$1.68 | $1.73 | $1.64 | $4.189M | 2.480M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 31201 | $1.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.73 | 59276 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 31201 | 1.720 |
3 | 61869 | 1.710 |
2 | 48877 | 1.705 |
3 | 9470 | 1.700 |
1 | 10000 | 1.690 |
Price($) | Vol. | No. |
---|---|---|
1.725 | 53096 | 5 |
1.730 | 41365 | 8 |
1.735 | 75814 | 5 |
1.740 | 21714 | 6 |
1.745 | 7000 | 2 |
Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Iggy Tan, Executive Chairman
Iggy Tan
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online